NO983677L - Trombinmuteiner som motmiddel mot trombininhibitorer - Google Patents

Trombinmuteiner som motmiddel mot trombininhibitorer

Info

Publication number
NO983677L
NO983677L NO983677A NO983677A NO983677L NO 983677 L NO983677 L NO 983677L NO 983677 A NO983677 A NO 983677A NO 983677 A NO983677 A NO 983677A NO 983677 L NO983677 L NO 983677L
Authority
NO
Norway
Prior art keywords
thrombin
gly
seq
antidote
natural human
Prior art date
Application number
NO983677A
Other languages
English (en)
Norwegian (no)
Other versions
NO983677D0 (no
Inventor
Martin Raditsch
Thomas Friedrich
Claus Bollschweiler
Martin Schmidt
Ffken Hans Wolfgang H
J Rgen Schweden
Bsamen Klaus R
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO983677L publication Critical patent/NO983677L/no
Publication of NO983677D0 publication Critical patent/NO983677D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO983677A 1996-02-12 1998-08-11 Trombinmuteiner som motmiddel mot trombininhibitorer NO983677D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19605126A DE19605126A1 (de) 1996-02-12 1996-02-12 Thrombinmuteine als Antidot für Thrombininhibitoren
PCT/EP1997/000612 WO1997029198A1 (de) 1996-02-12 1997-02-11 Thrombinmuteine als antidot für thrombininhibitoren

Publications (2)

Publication Number Publication Date
NO983677L true NO983677L (no) 1998-08-11
NO983677D0 NO983677D0 (no) 1998-08-11

Family

ID=7785198

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983677A NO983677D0 (no) 1996-02-12 1998-08-11 Trombinmuteiner som motmiddel mot trombininhibitorer

Country Status (18)

Country Link
US (1) US6060300A (de)
EP (1) EP0880591A1 (de)
JP (1) JPH11512621A (de)
KR (1) KR19990082479A (de)
CN (1) CN1211280A (de)
AR (1) AR005797A1 (de)
AU (1) AU1768497A (de)
BR (1) BR9707280A (de)
CA (1) CA2245546A1 (de)
CO (1) CO4600682A1 (de)
CZ (1) CZ247798A3 (de)
DE (1) DE19605126A1 (de)
HR (1) HRP970077A2 (de)
HU (1) HUP9900574A2 (de)
IL (1) IL125077A0 (de)
NO (1) NO983677D0 (de)
WO (1) WO1997029198A1 (de)
ZA (1) ZA971107B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000018933A (ko) * 1998-09-07 2000-04-06 김승수 내피세포 성장억제 활성을 가지는 사람 프로트롬빈 크링글단백질 및 이를 암호하는 유전자
GB2355161B (en) * 1999-10-05 2001-09-12 3Com Corp Network device incorporating selective compression of stored data packets
KR20020008471A (ko) * 2000-07-20 2002-01-31 김승수 내피세포 성장 억제활성을 가지는 인간 프로트롬빈크링글, 그것의 재조합벡터 및 이를 발현하는 재조합 숙주
WO2007103447A2 (en) * 2006-03-06 2007-09-13 Humagene, Inc. A method for the preparation of recombinant human thrombin
DK2193196T3 (en) * 2007-09-28 2016-11-07 Portola Pharm Inc Clinical profile of Factor Xa inhibitors, and methods of use thereof
US8268783B2 (en) 2007-09-28 2012-09-18 Portola Pharmaceuticals, Inc. Antidotes for factor Xa inhibitors and methods of using the same
WO2010056765A2 (en) 2008-11-14 2010-05-20 Portola Pharmaceuticals, Inc. Antidotes for factor xa inhibitors and methods of using the same in combination with blood coagulating agents
CA2767858C (en) 2009-07-15 2019-02-12 Portola Pharmaceuticals, Inc. Unit dose formulation of antidotes for factor xa inhibitors and methods of using the same
EP2316931B1 (de) * 2009-10-30 2016-12-28 Senova Gesellschaft für Biowissenschaft und Technik mbH Polymergekoppelte Peptidasen
TWI513466B (zh) 2010-01-20 2015-12-21 Boehringer Ingelheim Int 抗凝血劑解毒劑
PE20140964A1 (es) 2011-03-30 2014-08-17 Boehringer Ingelheim Int Antidotos anticoagulantes
CN106536566A (zh) 2014-05-26 2017-03-22 莱顿教学医院 用于出血治疗的促止血蛋白
EP3971576A1 (de) 2020-09-21 2022-03-23 Instrumentation Laboratory Company Nachweis und überwachung von oralen antikoagulantien oder intravenösen direkten thrombininhibitoren in einer blutprobe

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4203965A1 (de) * 1992-02-11 1993-08-12 Max Planck Gesellschaft Antidot fuer hirudin und synthetische thrombininhibitoren

Also Published As

Publication number Publication date
HUP9900574A2 (hu) 1999-06-28
WO1997029198A1 (de) 1997-08-14
HRP970077A2 (en) 1998-04-30
CN1211280A (zh) 1999-03-17
AR005797A1 (es) 1999-07-14
JPH11512621A (ja) 1999-11-02
NO983677D0 (no) 1998-08-11
IL125077A0 (en) 1999-01-26
BR9707280A (pt) 1999-07-20
CA2245546A1 (en) 1997-08-14
CZ247798A3 (cs) 1999-03-17
KR19990082479A (ko) 1999-11-25
ZA971107B (en) 1998-08-11
US6060300A (en) 2000-05-09
AU1768497A (en) 1997-08-28
DE19605126A1 (de) 1997-08-14
EP0880591A1 (de) 1998-12-02
CO4600682A1 (es) 1998-05-08

Similar Documents

Publication Publication Date Title
NO983677L (no) Trombinmuteiner som motmiddel mot trombininhibitorer
YU71395A (sh) Acilovani analozi insulina
DE10075019I2 (de) Neue Proteine mit TNF-Hemmender Wirkung und ihre Herstellung.
DK0593450T3 (da) Præparater omfattende omega-conotoxin-peptidderivater og deres anvendelse til behandling af neuronal beskadigelse med relation til iskæmi
ATE444360T1 (de) T-zell epitopen von den wichtigsten allergene von dermatophagoides (hausmilbe)
AR002282A1 (es) Polipeptidos utiles para detectar y/o tratar infestaciones con t. cruzi, composiciones farmaceuticas formuladas con dichos polipeptidos; equipos queincluyen dichos polipeptidos para el diagnostico de dichas infecciones, dna, vectores y celulas recombinantes transformadas con dicho dna.
HUP0000302A2 (hu) OB fúziós protein készítmények és módszerek
BRPI0412799A (pt) imunógeno, composição, ácido nucleico, célula recombinante, métodos para preparar um polipeptìdeo, para induzir um a resposta imune protetora em um paciente e para induzir uma resposta anamnésica em um paciente, e, seqüência de ácido nucleico otimizada de levedura
DK0579640T3 (da) Glialmitogene faktorer samt deres fremstilling og anvendelse
DK0921812T3 (da) Insulinpræparater, som indeholder NaCi
FR2842209B1 (fr) Nouvelle protease aspartique dite saspase et son utilisation dans le domaine cosmetique et therapeutique
DK0614980T3 (da) Trans-dominante TAT-varianter fra humant immundeficiens-virus
KR890000665A (ko) 크링글 치환이 있는 돌연변이체 t-PA
MX9203138A (es) Dominio de enlace cd2-de antigeno 3 (lfa-3) asociado con funcion linfositos.
ATE183775T1 (de) Cysteinfreie il-6 mutanten
MY104909A (en) Peptide compounds.
BR9714641A (pt) Mutantes de toxina a de estreptococo e métodos de uso
DK0418840T3 (da) Fremgangsmåder og materialer til resistens mod pheA feedback-inhibition
DK0918865T3 (da) Immunologisk aktive proteiner af Borrelia burgdorferi, derfor kodende nukleinsyrer samt deres anvendelse i testkits og som vacciner
ES2171563T3 (es) Nueva familia de inhibidores de proteasas, y otras sustancias de actividad biologica.
NO971517D0 (no) Peptider og farmasöytiske sammensetninger omfattende dem
DK270489D0 (da) Protein med thrombininhiberende virkning, fremgangsmaade til dets isolering, samt dets anvendelse som laegemiddel
KR880009127A (ko) 용성 성숙 hIL-β 및 변경된 생물학적 활성을 갖는 유도체를 이 콜라이에서 고도로 발현시키는 플라즈미드 및 그 방법
NO951277L (no) Desulfatohirudin med höy molekylvekt
KR900014592A (ko) 뇨 플라스미노겐 활성인자의 돌연변이체, 이의 생산방법 및 용도